For the very first time, Amsterdam, the Netherlands, will be the host city of our annual Biosimilar Medicines Conference, taking place on 28th and 29th of March 2019. As a key milestone in the biosimilar policy agenda, this 17th edition aims at fostering a multi-stakeholder forum conducive to achieving the needed advances. Delivering biological treatments to those in need as well as unlocking re-investment opportunities in the healthcare system will concentrate participants’ attention.
During these two interactive days, leaders and world experts in biosimilar medicines will gather and debate the evolving biosimilar medicines landscape and new trends. Discussion will focus on setting aims and implementing good practices to achieve the depth, breadth and speed of the use of biosimilar medicines as a lever to realise the access benefits.
The various sessions will cover all relevant areas of healthcare policy, market access, scientific developments, regulatory and clinical experience.
Join us and have your say!
As a participant in this event, you will
See here the list of companies/authorities/organisations present at the 2018 edition!
Lucia Romagnoli
M: +44 (0) 7 562 87 68 73
For more information on advertising, exhibition and sponsorship packages:
Trudy Beks
M: +31 6 4119 0824
Media Requirements and Press Policy
For any other media enquiries:
Andrea Bedorin
P: +32 (0)2 533 20 11
